NO920722L - Fremgangsmaate ved behandling av kroniske inflammatoriske lidelser - Google Patents

Fremgangsmaate ved behandling av kroniske inflammatoriske lidelser

Info

Publication number
NO920722L
NO920722L NO92920722A NO920722A NO920722L NO 920722 L NO920722 L NO 920722L NO 92920722 A NO92920722 A NO 92920722A NO 920722 A NO920722 A NO 920722A NO 920722 L NO920722 L NO 920722L
Authority
NO
Norway
Prior art keywords
treatment
chronic inflammatory
inflammatory disorders
procedure
patient
Prior art date
Application number
NO92920722A
Other languages
English (en)
Norwegian (no)
Other versions
NO920722D0 (no
Inventor
John Lawson Stanford
Graham Arthur William Rook
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of NO920722D0 publication Critical patent/NO920722D0/no
Publication of NO920722L publication Critical patent/NO920722L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Treatment Of Sludge (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO92920722A 1989-08-25 1992-02-24 Fremgangsmaate ved behandling av kroniske inflammatoriske lidelser NO920722L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898919321A GB8919321D0 (en) 1989-08-25 1989-08-25 Treatment of chronic inflammatory conditions
PCT/GB1990/001318 WO1991002542A1 (fr) 1989-08-25 1990-08-24 Traitement d'etats inflammatoires chroniques

Publications (2)

Publication Number Publication Date
NO920722D0 NO920722D0 (no) 1992-02-24
NO920722L true NO920722L (no) 1992-04-24

Family

ID=10662094

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920722A NO920722L (no) 1989-08-25 1992-02-24 Fremgangsmaate ved behandling av kroniske inflammatoriske lidelser

Country Status (13)

Country Link
US (1) US5833996A (fr)
EP (1) EP0489072B1 (fr)
JP (1) JP2987197B2 (fr)
AT (1) ATE135588T1 (fr)
AU (1) AU644813B2 (fr)
CA (1) CA2065286C (fr)
DE (1) DE69026094T2 (fr)
DK (1) DK0489072T3 (fr)
FI (1) FI920795A0 (fr)
GB (2) GB8919321D0 (fr)
NO (1) NO920722L (fr)
WO (1) WO1991002542A1 (fr)
ZA (1) ZA906753B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2095855C (fr) * 1990-11-08 2003-04-29 Graham A.W. Rook Emploi de mycobacterium comme adjuvant a des antigenes
GB9024320D0 (en) * 1990-11-08 1990-12-19 Univ London Treatment of uveitis
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
CA2164298A1 (fr) 1993-06-04 1994-12-22 Richard A. Young Proteines de stress et leur utilisation
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
GB9505658D0 (en) * 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics
US6056964A (en) * 1995-03-29 2000-05-02 Stanford Rook Limited Immunotherapeutic agent and its use
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AUPO359396A0 (en) * 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
US7157089B1 (en) 1996-11-26 2007-01-02 Stressgen Biotechnologies Corporation Immune responses using compositions containing stress proteins
KR100533818B1 (ko) * 1996-12-18 2005-12-07 스탠포드 룩 리미티드 면역계의 ｔｈ2 활성의 하향 조절을 위한 마이코박테리움 박케
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
RU2135196C1 (ru) * 1996-12-19 1999-08-27 Научно-исследовательский институт по изучению лепры Способ иммунопрофилактики экспериментальной лепрозной инфекции
ES2303351T3 (es) * 1997-04-01 2008-08-01 Thomas Julius Borody Metodos y composiciones para tratar enfermedades intestinales inflamatorias.
ES2266652T3 (es) 1997-08-05 2007-03-01 Stressgen Biotechnologies Corporation Respuestas inmunologicas contra los antigenos de hpv provocadas por compuestos que contienen un antigeno de hpv y una proteina de stress o un vector de expresion capaz de expresar dichas proteinas.
GB9723630D0 (en) * 1997-11-07 1998-01-07 Stanford Rook Ltd M.vaccae preparation and its use
RU2137137C1 (ru) * 1997-12-03 1999-09-10 Научно-исследовательский институт по изучению лепры Способ определения m.leprae у больных с регрессом заболевания
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
IL136821A0 (en) * 1997-12-23 2001-06-14 Genesis Res & Dev Corp Ltd Compositions derived from mycobacterium vaccae and methods for their use
US6497880B1 (en) 1998-12-08 2002-12-24 Stressgen Biotechnologies Corporation Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
GB9903539D0 (en) * 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
JP2003504074A (ja) 1999-07-08 2003-02-04 ストレスゲン バイオテクノロジーズ コーポレイション インビトロでのＴｈ１様応答の誘導
WO2001010221A1 (fr) * 1999-08-06 2001-02-15 Corixa Corporation Vaccins pour le traitement de maladies auto-immunes
AU1814101A (en) 2000-01-14 2001-07-24 Massachusetts Institute Of Technology In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete ATP binding domain and is CD4+ cell-independent
CZ20024154A3 (cs) 2000-06-26 2003-08-13 Stressgen Biotechnologies Corporation Použití prostředku obsahujícího napojený protein pro výrobu farmaceutického přípravku pro léčení bradavic a chorob a stavů souvisejících s papiloma virem
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
RU2295536C2 (ru) 2001-02-05 2007-03-20 Стрессджен Байотекнолоджиз Корп. Композиции на основе белка вируса гепатита в и стрессового белка и их применение
GB0106987D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeuitic agent
WO2003063759A2 (fr) 2002-01-31 2003-08-07 Peptor Ltd. Peptides de hsp et analogues pour la modulation des reponses immunitaires par l'intermediaire des cellules presentant l'antigene
EP1835933A4 (fr) 2005-01-04 2015-01-07 Yeda Res & Dev Hsp60, peptides hsp60 et vaccins a base de lymphocytes t pour immunomodulation
GB0526033D0 (en) * 2005-12-21 2006-02-01 Bioeos Ltd Method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2487198A1 (fr) * 1980-07-28 1982-01-29 Berri Balzac Sa Nouvelle substance immuno-suppressive, son procede d'isolement et son application en therapeutique
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
NL8701163A (nl) * 1986-09-09 1988-04-05 Nederlanden Staat Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits.
NL8703107A (nl) * 1987-12-22 1989-07-17 Nederlanden Staat Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten.
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
GB8917256D0 (en) * 1989-07-28 1989-09-13 Univ London Biological preparation and its use
CA2095855C (fr) * 1990-11-08 2003-04-29 Graham A.W. Rook Emploi de mycobacterium comme adjuvant a des antigenes

Also Published As

Publication number Publication date
ATE135588T1 (de) 1996-04-15
DE69026094D1 (de) 1996-04-25
FI920795A7 (fi) 1992-02-24
DE69026094T2 (de) 1996-08-22
AU6289790A (en) 1991-04-03
GB2252044B (en) 1993-09-22
EP0489072B1 (fr) 1996-03-20
ZA906753B (en) 1991-06-26
GB8919321D0 (en) 1989-10-11
US5833996A (en) 1998-11-10
EP0489072A1 (fr) 1992-06-10
JP2987197B2 (ja) 1999-12-06
GB2252044A (en) 1992-07-29
GB9203904D0 (en) 1992-04-15
DK0489072T3 (da) 1996-04-15
JPH05501870A (ja) 1993-04-08
NO920722D0 (no) 1992-02-24
AU644813B2 (en) 1993-12-23
WO1991002542A1 (fr) 1991-03-07
CA2065286C (fr) 2000-05-16
FI920795A0 (fi) 1992-02-24
CA2065286A1 (fr) 1991-02-26

Similar Documents

Publication Publication Date Title
NO920722L (no) Fremgangsmaate ved behandling av kroniske inflammatoriske lidelser
NO871512D0 (no) Kontinuerlig fremgangsmaate for tablettering og apparat for utfoerelse av fremgangsmaaten.
NO934500L (no) Ikke-klorfluorcarbonaerosolformuleringer
DK0396404T3 (da) Farmaceutisk middel indeholdende loratadin, ibuprofen og pseudoephedrin
NO870819L (no) FremgangsmŸte, system og apparat ved intravaskulŸr ultralyd-billeddannelse.
JPS52108692A (en) Adjusting device for joint portion of medical treatment or examination apparatus
NO832334L (no) Fremgangsmaate og apparat for fremstilling av risledyktig prill-materiale.
DK524483A (da) Fremgangsmaade og apparat til at diagnosticere oeresygdomme
DK389889D0 (da) Fremgangsmaade og apparat til estimering af legemskonturer i viftestraaleberegnede tomografisystemer
Lamb Prognosis for the infertile couple
NO873074L (no) Fremgangsmaate og apparat for fremstilling av spiralsnodde roerknipper.
JPS6458251A (en) Dental arch
IT8124060A0 (it) Apparecchiatura a raggi x per panorama tomografico particolarmente per la radiografia della regione cranica e del collodi un paziente disteso.
ES532286A0 (es) Metodo in vitro para detectar un estado maligno en un paciente humano.
Mortensen et al. Ventilation tubes and cholesteatoma in children
IT1126572B (it) Derivato del paracetamol,procedimento per la sua preparazione e suo impiego nel campo terapeutico
Lopez Tuberculosis and the severely mentally ill.
FR2585710B1 (fr) Copolymere hydrophile convenant surtout aux lentilles de contact et aux applications medicales, et procede pour sa preparation
FI841988A7 (fi) Immunosuppressiivista tekijää tuottava mutantti, humaani T-solulinja sekä menetelmä sellaisten mutanttien tuottamiseksi.
NL7803642A (nl) Individuele endo-osseo inplant voor odonto-stomalogie (mondchirurgie) en werkwijze voor de snelle en perfek- te aanbrenging van de inplant in de patient.
Babich et al. Heat Treatment of Railroad Rails
SU586577A1 (ru) Контактное устройство
FR2376656A1 (fr) Appareil pour le traitement chirurgical des os et des articulations
Robinson et al. The Nottingham ECT Study: Double-Blind?
Welizarowicz et al. State of health of workers employed in the phosphates production. Part III. General and specialistic medical examinations.